An HIV-1 antibody from an elite neutralizer implicates the combination peptide as a niche site of vulnerability
An HIV-1 antibody from an elite neutralizer implicates the combination peptide as a niche site of vulnerability Affiliations 1 office of health Microbiology, Academic infirmary, institution of Amsterdam, 1105 AZ, Amsterdam, holland. 2 section of Immunology and Microbial art, Scripps CHAVI-ID, IAVI Neutralizing Antibody hub and partnership for SUPPORTS Vaccine knowledge (CAVD), The Scripps analysis …